
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5314D58AEF5F130514D50006D72AE1.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373793/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma">
<meta name="citation_author" content="Ruiqi Wang">
<meta name="citation_author_institution" content="Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China">
<meta name="citation_author" content="Hao Tian">
<meta name="citation_author_institution" content="Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China">
<meta name="citation_author" content="Zhenxing Zhu">
<meta name="citation_author_institution" content="Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China">
<meta name="citation_author" content="Dan Cong">
<meta name="citation_author_institution" content="Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China">
<meta name="citation_author" content="Yuansong Bai">
<meta name="citation_author_institution" content="Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China">
<meta name="citation_author" content="Wenlong Zhang">
<meta name="citation_author_institution" content="Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China">
<meta name="citation_publication_date" content="2025 Aug 23">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="30992">
<meta name="citation_doi" content="10.1038/s41598-025-15360-7">
<meta name="citation_pmid" content="40846723">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373793/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373793/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373793/pdf/41598_2025_Article_15360.pdf">
<meta name="description" content="To evaluate the clinical value of polyethylene glycolized recombinant human granulocyte-stimulating factor (PEG-rhG-CSF) for hematopoietic reconstitution after autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM) ...">
<meta name="og:title" content="The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="To evaluate the clinical value of polyethylene glycolized recombinant human granulocyte-stimulating factor (PEG-rhG-CSF) for hematopoietic reconstitution after autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM) ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373793/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373793">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-15360-7"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_15360.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373793%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373793/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373793/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373793/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 23;15:30992. doi: <a href="https://doi.org/10.1038/s41598-025-15360-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-15360-7</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Ruiqi Wang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Ruiqi Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ruiqi Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Hao Tian</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Hao Tian</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hao Tian</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Zhenxing Zhu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Zhenxing Zhu</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhenxing Zhu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cong%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Dan Cong</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Dan Cong</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cong%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dan Cong</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bai%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yuansong Bai</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yuansong Bai</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bai%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuansong Bai</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Wenlong Zhang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Wenlong Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenlong Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, 130033 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 6; Accepted 2025 Aug 7; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373793  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40846723/" class="usa-link">40846723</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">To evaluate the clinical value of polyethylene glycolized recombinant human granulocyte-stimulating factor (PEG-rhG-CSF) for hematopoietic reconstitution after autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (NDMM) patients. This study analyzed data from 70 NDMM patients undergoing ASCT, with 33 receiving PEG-rhG-CSF and 37 receiving rhG-CSF. The median time of neutrophil and platelet engraftment, median transfusions of blood products, treatment-related adverse reactions, long-term hematopoietic reconstitution and economic benefits were compared between the two groups. Both groups had similar median neutrophil engraftment, but PEG-rhG-CSF resulted in slower platelet engraftment (13.7 vs. 11.4 days, <em>p</em> &lt; 0.001), more platelet transfusions (2.9 vs. 1.6 units, <em>p</em> &lt; 0.001), higher incidence of grade ≥ 3 diarrhea (60.6 vs. 29.7%, <em>p</em> = 0.006), longer diarrhea duration (9.0 vs. 5.5 days, <em>p</em> = 0.004), and higher costs (RMB 77,126 vs. RMB 68,361, <em>p</em> = 0.027). PEG-rhG-CSF support post-ASCT in NDMM led to slower platelet engraftment, greater platelet transfusion requirements, increased incidence and duration of severe diarrhea, and greater costs, indicating its potential as an expensive treatment option.</p>
<section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Recombinant human granulocyte stimulating factor, Newly diagnosed multiple myeloma, Autologous stem cell transplantation, Hematopoietic reconstitution</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Haematological cancer, Haematopoietic stem cells</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">The current standard treatment approach for newly diagnosed multiple myeloma (NDMM) eligible for transplantation involves induction therapy followed by sequential autologous stem cell transplantation (ASCT) consolidation<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Conditioning regimens preceding autologous stem cell transplantation frequently utilize high-dose chemotherapy, leading to significant neutropenia and thrombocytopenia that elevate the susceptibility to infections and hemorrhages, thereby contributing to early transplantation-related mortality<sup><a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. The process of hematopoietic reconstitution following ASCT is a crucial component of therapeutic intervention in multiple myeloma (MM). This process is influenced by several factors, including the patient’s overall health status, the disease condition prior to transplantation, the number of infused CD34+ cells, and the specific type of granulocyte colony-stimulating factor (G-CSF) utilized<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>. Studies have shown that the use of recombinant human granulocyte stimulating factor (rhG-CSF) enhances neutrophil engraftment following ASCT in individuals with MM, leading to a decrease in the duration of granulocytopenia and a subsequent reduction in the occurrence of severe infections during hematopoietic recovery<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>. Consequently, rhG-CSF is commonly employed as adjunctive treatment to facilitate hematopoietic reconstitution post-ASCT.</p>
<p id="Par3">Polyethylene glycolized recombinant human granulocyte stimulating factor (PEG-rhG-CSF) is a sustained-release formulation of rhG-CSF that has been modified through polyethylene glycolization. This modification reduces plasma clearance, extending the half-life of the drug while preserving its biological activity. PEG-rhG-CSF offers enhanced drug solubility, improved bioavailability, and increased stability of the formulation<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. Clinical trials have demonstrated that the efficacy and safety of PEG-rhG-CSF in the prevention of febrile neutropenia (FN) following chemotherapy for lymphomas and solid tumors is comparable to that of rhG-CSF<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. Due to its demonstrated efficacy, convenience, and cost-effectiveness, PEG-rhG-CSF has received approval for use in prophylaxis against COVID-19 infection and FN following chemotherapy in patients with solid tumors<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>–<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>.</p>
<p id="Par4">Nevertheless, there is a scarcity of studies comparing the effectiveness of PEG-rhG-CSF and rhG-CSF for hematopoietic reconstitution following ASCT in patients with NDMM. Therefore, we carried out a retrospective study in a real-world setting to assess the effectiveness, safety, and cost-efficiency of PEG-rhG-CSF versus rhG-CSF for hematopoietic reconstitution after ASCT in NDMM.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Patients</h3>
<p id="Par5">This study conducted a retrospective analysis of 70 patients with NDMM who underwent ASCT at the China-Japan Union Hospital, Jilin University, between January 2018 and June 2023. Prior to January 2021, rhG-CSF was the standard treatment protocol at our institution. However, since 2021, accumulating evidence from multiple randomized controlled trials and observational studies has highlighted the clinical benefits of PEG-rhG-CSF over rhG-CSF<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>–<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. As a result, the majority of patients treated from January 2021 onward were transitioned to PEG-rhG-CSF. Patients were categorized based on the type of G-CSF administered post-ASCT, with 33 patients in the PEG-rhG-CSF cohort and 37 patients in the rhG-CSF cohort. Prior to ASCT, all patients underwent Durie–Salmon (DS) staging, International Staging System (ISS) staging, Revised International Staging System (R-ISS), mSMART 3.0 risk stratification, and assessment of disease response status<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>. Informed consent was obtained from all patients, permitting the use of their data for research purposes. The study received approval from the Ethics Committee of China-Japan Union Hospital of Jilin University. All research methods were performed in accordance with the relevant guidelines and regulations. Patient data was extracted from the hospital’s electronic record management system. Participants in the study were required to meet specific criteria, including being newly diagnosed with multiple myeloma, being aged 65 or younger, undergoing induction therapy with 4 cycles of bortezomib plus lenalidomide and dexamethasone (BRD) regimen to achieve complete remission (CR), very good partial response (VGPR), or partial response (PR) before transplantation, having no evidence of relapse or refractory disease, possessing appropriate organ function (defined as left ventricular ejection fraction ≥ 40%, exertional expiratory volume in 1 s or exertional lung volume in second ≥ 40% of predicted value, and creatinine clearance ≥ 40 ml/min), and having an ECOG score of ≤ 2 (Fig. <a href="#Fig1" class="usa-link">1</a>). Lenalidomide was administered at a dosage of 25 mg daily from day 1 to day 14, with the treatment cycle repeating every 21 days<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373793_41598_2025_15360_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69f1/12373793/56c0a813526c/41598_2025_15360_Fig1_HTML.jpg" loading="lazy" id="MO1" height="303" width="677" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Processes for grouping NDMM patients suitable for ASCT who participated in our retrospective study. NDMM, newly diagnosed multiple myeloma; ASCT, autologous stem cell transplantation; BRD, bortezomib, lenalidomide and dexamethasone; PEG-rhG-CSF, polyethylene glycolized recombinant human granulocyte-stimulating factor; rhG-CSF, recombinant human granulocyte-stimulating factor.</p></figcaption></figure></section><section id="Sec4"><h3 class="pmc_sec_title">Conditioning regimen</h3>
<p id="Par6">All patients were administered intravenous melphalan at a total dose of 200 mg/m<sup>2</sup> on days − 3 and − 2 preceding autologous stem cell transplantation (ASCT).</p></section><section id="Sec5"><h3 class="pmc_sec_title">Supportive care</h3>
<p id="Par7">All patients received a prophylactic regimen consisting of 50 mg of fluconazole daily for <em>Candida</em> infection prevention, a double-strength tablet (160/800 mg) of cotrimoxazole taken three times weekly on alternate days to prevent <em>Pneumocystis jirovecii</em> infection pneumonia, and 400 mg of acyclovir twice daily for herpesvirus prevention<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>,<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. Additionally, hepatitis B virus-infected individuals were administered 0.5 mg of entecavir daily to prevent hepatitis B virus activation<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>,<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>,<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>. Kangfuxin liquid, a traditional Chinese medicine, was routinely administered during pretreatment and hematopoietic reconstitution to prevent oral mucosal ulcers. In cases of oral mucosal ulcers, the treatment regimen included a combination of oral gel and supplementation with multivitamins and micronutrients. In the PEG-rhG-CSF cohort, a subcutaneous dose of 100 μg/kg of PEG-rhG-CSF was administered 48 h subsequent to the transfusion of autologous hematopoietic stem cells<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>. In instances where FN manifested following ASCT reinfusion, supplementary rhG-CSF was administered at a dosage of 5 µg/kg/day until neutrophil engraftment was achieved. FN is defined as a single oral temperature of ≥ 38.3 °C or ≥ 38 °C for over an hour, with an absolute neutrophil count &lt; 0.5 × 10<sup>9</sup>/L or &lt; 1 × 10<sup>9</sup>/L expected to drop to 0.5 × 10<sup>9</sup>/L within 48 h. The rhG-CSF group receiving rhG-CSF was administered a dosage of 5 μg/kg/day beginning on day 6 following autologous stem cell transfusion and continuing until neutrophil engraftment. A red blood cell suspension was administered when the hemoglobin level fell below 60 g/L, while platelets were transfused when the platelet count dropped below 20 × 10<sup>9</sup>/L. Throughout the process of hematopoietic reconstitution, patients experiencing FN are prescribed anti-bacterial and anti-fungal medications on a personalized basis.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Response assessment criteria</h3>
<p id="Par8">The impact of PEG-rhG-CSF and rhG-CSF on short-term hematopoietic reconstitution (SHR), adverse reactions prior to SHR were evaluated as short-term response.</p>
<p id="Par9">The SHR criteria is defined as neutrophil and platelet engraftment<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. Neutrophil engraftment is achieved when the absolute neutrophil count (ANC) is ≥ 0.5 × 10<sup>9</sup>/L for three consecutive days, while platelet engraftment is achieved when the platelet count is ≥ 20 × 10<sup>9</sup>/L for three consecutive days without the need for platelet transfusion<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>.</p>
<p id="Par10">ASCT-related adverse reactions were determined by referring to the Common Terminology Criteria for Adverse Events, version 5.0<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>.</p>
<p id="Par11">The impact of PEG-rhG-CSF and rhG-CSF on long-term hematopoietic and immune reconstitution was assessed at 6 months following ASCT as long-term response<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. The assessment of immune reconstitution was conducted through the analysis of lymphocyte subsets and the quantification of immunoglobulin levels. Hematopoietic reconstitution was assessed by conducting a complete blood count analysis.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Economic benefits</h3>
<p id="Par12">To conduct a comparative analysis of the median duration of hospital stays and the median hospitalization costs (expressed in RMB) between the two cohorts.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par13">Statistical analyses were conducted utilizing the Statistical Package for the Social Sciences (SPSS) software, version 29.0. For group comparisons adhering to a normal distribution, the Student’s t-test was employed. In cases where the data did not conform to a normal distribution, the Mann–Whitney U-test was applied. The chi-square test was utilized to assess differences in the incidence of specific variables between the two groups. All <em>p</em>-values were two-tailed, with a threshold of <em>p</em> &lt; 0.05 set for statistical significance.</p></section></section><section id="Sec9"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec10"><h3 class="pmc_sec_title">Patient characteristics</h3>
<p id="Par14">Table <a href="#Tab1" class="usa-link">1</a> provides an overview of patient characteristics before ASCT. The median age of the cohort was 55.2 years, with an age range of 36 to 70 years. The gender distribution was 60% male and 40% female. Patients at DS stages II and III comprised 7.1% and 92.9% of the cohort, respectively. The distribution of patients across ISS stages I, II, and III was 31.4%, 32.9%, and 35.7%, respectively. According to the R-ISS, 27.1% of patients were classified as stage I, 45.7% as stage II, and 27.1% as stage III. In terms of the mSMART 3.0 classification, 54.3% of patients were identified as high-risk, while 45.7% were categorized as standard-risk. Prior to ASCT, 65.7% of patients achieved a complete response (CR), 30% achieved a very good partial response (VGPR), and 4.3% achieved a partial response (PR). There were no statistically significant differences observed in median age, sex ratio, proportion of initial DS staging, ISS staging, R-ISS staging, risk stratification, and pre-transplantation disease status between patients in the PEG-rhG-CSF group and rhG-CSF group (<em>p</em> &gt; 0.05).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>General characteristics of patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">PEG-rhG-CSF (n = 33)</th>
<th align="left" colspan="1" rowspan="1">rhG-CSF (n = 37)</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"> Median age, years (range)</td>
<td align="left" colspan="1" rowspan="1">55.8 (41–69)</td>
<td align="left" colspan="1" rowspan="1">54.8 (36–70)</td>
<td align="center" colspan="1" rowspan="1">0.587</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Sex, n (%)</td>
<td align="center" rowspan="3" colspan="1">0.224</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">17 (51.5%)</td>
<td align="left" colspan="1" rowspan="1">25 (67.6%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">16 (48.5%)</td>
<td align="left" colspan="1" rowspan="1">12 (32.4%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Induction therapy protocols</td>
<td align="left" colspan="1" rowspan="1">BRD</td>
<td align="left" colspan="1" rowspan="1">BRD</td>
<td align="center" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">DS staging, n (%)</td>
<td align="center" rowspan="4" colspan="1">0.357</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> I</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> II</td>
<td align="left" colspan="1" rowspan="1">3 (9.1%)</td>
<td align="left" colspan="1" rowspan="1">2 (5.4%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> III</td>
<td align="left" colspan="1" rowspan="1">30 (90.9%)</td>
<td align="left" colspan="1" rowspan="1">35 (95.6%)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">ISS staging, n (%)</td>
<td align="center" rowspan="4" colspan="1">0.637</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> I</td>
<td align="left" colspan="1" rowspan="1">11 (33.3%)</td>
<td align="left" colspan="1" rowspan="1">11 (29.7%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> II</td>
<td align="left" colspan="1" rowspan="1">9 (27.3%)</td>
<td align="left" colspan="1" rowspan="1">14 (37.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> III</td>
<td align="left" colspan="1" rowspan="1">13 (39.4%)</td>
<td align="left" colspan="1" rowspan="1">12 (32.4%)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">R-ISS staging, n (%)</td>
<td align="center" rowspan="4" colspan="1">0.424</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> I</td>
<td align="left" colspan="1" rowspan="1">8 (24.2%)</td>
<td align="left" colspan="1" rowspan="1">11 (29.7%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> II</td>
<td align="left" colspan="1" rowspan="1">15 (45.5%)</td>
<td align="left" colspan="1" rowspan="1">17 (45.9%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> III</td>
<td align="left" colspan="1" rowspan="1">10 (30.3%)</td>
<td align="left" colspan="1" rowspan="1">9 (24.3%)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Classification of active MM (mSMART 3.0), n (%)</td>
<td align="center" rowspan="3" colspan="1">0.091</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> High-risk</td>
<td align="left" colspan="1" rowspan="1">17 (51.5%)</td>
<td align="left" colspan="1" rowspan="1">21 (56.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Standard-risk</td>
<td align="left" colspan="1" rowspan="1">16 (48.5%)</td>
<td align="left" colspan="1" rowspan="1">16 (43.2%)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1">Disease status at ASCT, n (%)</td>
<td align="center" rowspan="4" colspan="1">1.299</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> CR</td>
<td align="left" colspan="1" rowspan="1">23 (69.7%)</td>
<td align="left" colspan="1" rowspan="1">23 (62.2%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> VGPR</td>
<td align="left" colspan="1" rowspan="1">8 (24.2%)</td>
<td align="left" colspan="1" rowspan="1">13 (35.1%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> PR</td>
<td align="left" colspan="1" rowspan="1">2 (6.1%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.7%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p17"><p>PEG-rhG-CSF, Polyethylene glycolized recombinant human granulocyte-stimulating factor; rhG-CSF, Recombinant human granulocyte-stimulating factor; BRD, Bortezomib, lenalidomide and dexamethasone; DS staging, Durie–Salmon staging; ISS, International staging system; R-ISS, Revised international staging system; MM, Multiple myeloma; mSMART, Mayo stratification of myeloma and risk-adapted therapy; CR, Complete remission; VGPR, Very good partial response; PR, Partial response.</p></div></div></section></section><section id="Sec11"><h3 class="pmc_sec_title">Short-term hematopoietic reconstitution</h3>
<p id="Par15">The median number of CD34+ cells transfused in the PEG-rhG-CSF group and the rhG-CSF group was 3.6 × 10<sup>6</sup>/kg and 3.8 × 10<sup>6</sup>/kg, respectively. This difference was not statistically significant (<em>p</em> = 0.793), as illustrated in Table <a href="#Tab2" class="usa-link">2</a> and Fig. <a href="#Fig2" class="usa-link">2</a>A. Additionally, 22 cases (66.7%) in the PEG-rhG-CSF group received supplementary treatment with rhG-CSF during FN. The median duration of supplementary rhG-CSF administration in this group was 4 days, with a range of 2 to 11 days. In the PEG-rhG-CSF cohort, four patients necessitated the administration of red blood cell suspensions, whereas in the rhG-CSF cohort, two patients required such intervention. The median number of transfused red blood cell suspension in the PEG-rhG-CSF cohort was 0 units, with a range of 0 to 3.5 units. Similarly, the median number in the rhG-CSF cohort was also 0 units, with a range spanning from 0 to 4 units. Statistical analysis indicated that there was no statistically significant difference between the two groups (<em>p</em> = 0.397) (refer to Fig. <a href="#Fig2" class="usa-link">2</a>B). In the PEG-rhG-CSF cohort, all 33 patients (100%) underwent platelet transfusion, whereas in the rhG-CSF cohort, 35 patients (94.6%) received platelet transfusions. The median number of platelet units transfused was 2.9 in the PEG-rhG-CSF group and 1.6 in the rhG-CSF group, with a statistically significant difference (<em>p</em> &lt; 0.001) (Fig. <a href="#Fig2" class="usa-link">2</a>C). The median time to neutrophil engraftment in the PEG-rhG-CSF and rhG-CSF groups was 11.3 and 11 days, respectively (<em>p</em> = 0.324) (Fig. <a href="#Fig2" class="usa-link">2</a>D). The median time to platelet engraftment differed significantly between the two groups, with values of 13.7 and 11.4 days, respectively (<em>p</em> &lt; 0.001) as shown in Fig. <a href="#Fig2" class="usa-link">2</a>E. While the duration of neutropenia and antibiotic treatment was longer in the PEG-rhG-CSF group (7.3 and 6.8 days, <em>p</em> = 0.249; 10 and 8.8 days, <em>p</em> = 0.207, respectively), these differences were not statistically significant. The post-transplantation neutrophil and platelet change curves demonstrated a consistent pattern of recovery in both groups. Specifically, an increase in neutrophil count was observed on day +9, with the curve for the PEG-rhG-CSF group showing a slower rise compared to the rhG-CSF group (Fig. <a href="#Fig2" class="usa-link">2</a>F). The increase in platelet levels was observed on day +11 in the PEG-rhG-CSF group, while in the rhG-CSF group, this increase was noted on day +9, with platelet counts surpassing those of the PEG-rhG-CSF group (Fig. <a href="#Fig2" class="usa-link">2</a>G).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>The effects of PEG-rhG-CSF and rhG-CSF on short-term hematopoietic reconstitution.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">PEG-rhG-CSF</th>
<th align="left" colspan="1" rowspan="1">rhG-CSF</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Median number of reinfused CD34 + cells, × 10<sup>6</sup>/kg (range)</td>
<td align="left" colspan="1" rowspan="1">3.6 (1.9–8.1)</td>
<td align="left" colspan="1" rowspan="1">3.8 (1.49–10.5)</td>
<td align="center" colspan="1" rowspan="1">0.793</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median number of RBC infusions, units (range)</td>
<td align="left" colspan="1" rowspan="1">0.3 (0–3.5)</td>
<td align="left" colspan="1" rowspan="1">0.2 (0–4)</td>
<td align="center" colspan="1" rowspan="1">0.594</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median number of PLT transfusions, units (range)</td>
<td align="left" colspan="1" rowspan="1">2.9 (1–8)</td>
<td align="left" colspan="1" rowspan="1">1.6 (0–4)</td>
<td align="center" colspan="1" rowspan="1"> &lt; <em>0.001</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median time to ANC &gt; 0.5 × 10<sup>9</sup>/L, days (range)</td>
<td align="left" colspan="1" rowspan="1">11.3 (9–21)</td>
<td align="left" colspan="1" rowspan="1">11.0 (9–13)</td>
<td align="center" colspan="1" rowspan="1">0.324</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median time to PLTc &gt; 20 × 10<sup>9</sup>/L, days (range)</td>
<td align="left" colspan="1" rowspan="1">13.7 (10–24)</td>
<td align="left" colspan="1" rowspan="1">11.4 (8–16)</td>
<td align="center" colspan="1" rowspan="1"> &lt; <em>0.001</em>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Duration of neutropenia, days (range)</td>
<td align="left" colspan="1" rowspan="1">7.3 (5–8)</td>
<td align="left" colspan="1" rowspan="1">6.8 (6–9)</td>
<td align="center" colspan="1" rowspan="1">0.249</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median days on parenteral antibiotics, (range)</td>
<td align="left" colspan="1" rowspan="1">10.0 (5–18)</td>
<td align="left" colspan="1" rowspan="1">8.8 (0–20)</td>
<td align="center" colspan="1" rowspan="1">0.207</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median days of hospitalization, (range)</td>
<td align="left" colspan="1" rowspan="1">27.1 (20–34)</td>
<td align="left" colspan="1" rowspan="1">26.4 (16–41)</td>
<td align="center" colspan="1" rowspan="1">0.499</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median hospitalization cost, RMB (range)</td>
<td align="left" colspan="1" rowspan="1">77,126 (49,909–107,881)</td>
<td align="left" colspan="1" rowspan="1">68,361 (38,532–116,275)</td>
<td align="center" colspan="1" rowspan="1"><em>0.027</em></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Number of patients who received RBC transfusions, n (%)</td>
<td align="left" colspan="1" rowspan="1">4 (12.1%)</td>
<td align="left" colspan="1" rowspan="1">2 (5.4%)</td>
<td align="center" colspan="1" rowspan="1"> &gt; 0.99</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Number of patients who received platelet transfusions, n (%)</td>
<td align="left" colspan="1" rowspan="1">33 (100%)</td>
<td align="left" colspan="1" rowspan="1">35 (94.6%)</td>
<td align="center" colspan="1" rowspan="1"> &gt; 0.99</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p20">
<p>RBC, Red blood cell; PLTc, Platelet count; ANC, Absolute neutrophil count; G-CSF, Granulocyte colony-stimulating factor.</p>
<p>Significant values are in italics</p>
</div></div></section><figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373793_41598_2025_15360_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69f1/12373793/ce7025c8065d/41598_2025_15360_Fig2_HTML.jpg" loading="lazy" id="MO2" height="350" width="661" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Hematopoietic reconstitution after ASCT in the PEG-rhG-CSF and rhG-CSF groups. (<strong>A</strong>) median number of CD34+ cells transfused in both groups; (<strong>B</strong>) median number of red cell suspensions transfused during hematopoietic reconstitution; (<strong>C</strong>) median number of platelets transfused during hematopoietic reconstitution; (<strong>D</strong>) median time to neutrophil engraftment; (<strong>E</strong>) median time to platelet engraftment; (<strong>F</strong>) curve plot of neutrophil counts after ASCT; (<strong>G</strong>) curve plot of platelet counts after ASCT.</p></figcaption></figure></section><section id="Sec12"><h3 class="pmc_sec_title">ASCT related adverse reactions prior to SHR</h3>
<p id="Par16">The ASCT related adverse reactions prior to SHR exhibited comparable characteristics in both cohorts as illustrated in Table <a href="#Tab3" class="usa-link">3</a>. The predominant hematologic adverse reactions observed were grade ≥ 3 neutropenia and thrombocytopenia, demonstrating a notable level of concordance in occurrence rates across the two study groups. The prevalence of anemia in the study population was predominantly mild to moderate, with no statistically significant variance observed between the comparison groups. The majority of non-hematologic adverse reactions were graded as ≤ 2 and encompassed symptoms such as nausea and vomiting (81.8 vs. 73%, <em>p</em> = 0.379), elevated transaminases (15.2 vs. 10.8%, <em>p</em> = 0.726), elevated bilirubin (24.2 vs. 27%, <em>p</em> = 0.790), elevated creatinine (6.1 vs. 10.8%, <em>p</em> = 0.677), and fever (48.6 vs. 63.6%, <em>p</em> = 0.157), with no statistically significant distinction between the two cohorts. The prevalence of diarrhea in the two cohorts was 90.9% and 91.9%, respectively, with grade 1–2 diarrhea observed in 30.3% (n = 10) of patients in the PEG-rhG-CSF group and 62.2% (n = 23) in the rhG-CSF group. Grade 3–4 diarrhea was reported in 60.6% (n = 20) of patients in the PEG-rhG-CSF group and 29.7% (n = 11) in the rhG-CSF group (<em>p</em> = 0.006). The median duration of diarrhea in the PEG-rhG-CSF group was significantly longer compared to the control group (9 days vs. 6 days, <em>p</em> = 0.004). There was no statistically significant difference observed between the two groups in terms of the median duration of nausea and vomiting (5 and 4 days, <em>p</em> = 0.141) and the median number of days receiving intravenous nutrition (7 and 6 days, <em>p</em> = 0.330). The primary adverse reaction linked to the administration of G-CSF was bone pain, which manifested at comparable frequencies in both cohorts (12.1% and 8.1%, <em>p</em> = 0.699).</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>The effects of PEG-rhG-CSF and rhG-CSF on ASCT related adverse reactions prior to short-term hematopoietic reconstitution and mortality within 100 days post-transplant.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">PEG-rhG-CSF</th>
<th align="left" colspan="1" rowspan="1">rhG-CSF</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em> value</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="4" rowspan="1">Hematologic toxicity</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Neutropenia, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"> &gt; 0.999</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade I–II</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade III–IV</td>
<td align="left" colspan="1" rowspan="1">33 (100%)</td>
<td align="left" colspan="1" rowspan="1">37 (100%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anemia, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.832</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade I–II</td>
<td align="left" colspan="1" rowspan="1">17 (51.5%)</td>
<td align="left" colspan="1" rowspan="1">20 (54.1%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade III–IV</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Thrombocytopenia, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"> &gt; 0.999</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade I–II</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade III–IV</td>
<td align="left" colspan="1" rowspan="1">100%</td>
<td align="left" colspan="1" rowspan="1">100%</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="4" rowspan="1">Non-hematological toxicity</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Fever, n (%)</td>
<td align="left" colspan="1" rowspan="1">21 (63.6%)</td>
<td align="left" colspan="1" rowspan="1">18 (48.6%)</td>
<td align="center" colspan="1" rowspan="1">0.157</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Gastrointestinal toxicity</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Nausea and vomiting, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.379</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade I–II</td>
<td align="left" colspan="1" rowspan="1">27 (81.8%)</td>
<td align="left" colspan="1" rowspan="1">27 (73%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade III–IV</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Diarrhea, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"><em>0.006</em></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade I–II</td>
<td align="left" colspan="1" rowspan="1">10 (30.3%)</td>
<td align="left" colspan="1" rowspan="1">23 (62.2%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade III–IV</td>
<td align="left" colspan="1" rowspan="1">20 (60.6%)</td>
<td align="left" colspan="1" rowspan="1">11 (29.7%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hepatotoxicity</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Elevated transaminase, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.726</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade I–II</td>
<td align="left" colspan="1" rowspan="1">5 (15.2%)</td>
<td align="left" colspan="1" rowspan="1">4 (10.8%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade III–IV</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Elevated bilirubin, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.790</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade I–II</td>
<td align="left" colspan="1" rowspan="1">8 (24.2%)</td>
<td align="left" colspan="1" rowspan="1">10 (27%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade III–IV</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Renal toxicity</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Elevated blood creatinine, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.677</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade I–II</td>
<td align="left" colspan="1" rowspan="1">2 (6.1%)</td>
<td align="left" colspan="1" rowspan="1">4 (10.8%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Grade III–IV</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Bacterial pathogens, n (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.093</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Gram-positive bacteria, n (%)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Gram-negative bacteria, n (%)</td>
<td align="left" colspan="1" rowspan="1">5 (15.2%)</td>
<td align="left" colspan="1" rowspan="1">1 (2.7%)</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median days of diarrhea, n (range)</td>
<td align="left" colspan="1" rowspan="1">9 (0–22)</td>
<td align="left" colspan="1" rowspan="1">6 (0–15)</td>
<td align="center" colspan="1" rowspan="1"><em>0.004</em></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Median days of nausea and vomiting, n (range)</td>
<td align="left" colspan="1" rowspan="1">5 (0–27)</td>
<td align="left" colspan="1" rowspan="1">4 (0–12)</td>
<td align="center" colspan="1" rowspan="1">0.141</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Days of intravenous nutrition, n (range)</td>
<td align="left" colspan="1" rowspan="1">7 (0–22)</td>
<td align="left" colspan="1" rowspan="1">6 (0–17)</td>
<td align="center" colspan="1" rowspan="1">0.574</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Death within 100 days post-transplant, n (%)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="center" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p25">
<p>PEG-rhG-CSF, Polyethylene glycolized recombinant human granulocyte-stimulating factor; rhG-CSF, Recombinant human granulocyte-stimulating factor.</p>
<p>Significant values are in italics</p>
</div></div></section></section><section id="Sec13"><h3 class="pmc_sec_title">Long-term hematopoietic reconstitution and immune reconstitution follow-up</h3>
<p id="Par17">There were 2 instances of loss to follow-up in each group. At 6 months post-ASCT, the median neutrophil counts of patients who remained in the study were 2.9 × 10<sup>9</sup>/L in the PEG-rhG-CSF group and 3.1 × 10<sup>9</sup>/L in the rhG-CSF group (<em>p</em> = 0.386) (Table <a href="#Tab4" class="usa-link">4</a>). The median hemoglobin levels were 124.1 g/L and 124.7 g/L, respectively (<em>p</em> = 0.925). Additionally, the median platelet counts were 153.1 × 10<sup>9</sup>/L in the PEG-rhG-CSF group and 141.9 × 10<sup>9</sup>/L in the rhG-CSF group (<em>p</em> = 0.397), indicating no statistically significant differences between the two groups. The median lymphocyte counts of patients were 1082 /ul in the PEG-rhG-CSF group and 1162 /ul in the rhG-CSF group (<em>p</em> = 0.397). There was no statistically significant difference in the counts of CD4+ , CD8+ , CD19+ and CD3+ CD56+ lymphocytes between the two groups of patients. The median levels of immunoglobulin G, immunoglobulin A, and immunoglobulin M were comparable between the two patient groups, with no statistically significant differences observed.</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>The effects of PEG-rhG-CSF and rhG-CSF on long-term hematopoietic reconstitution and immune reconstitution at 6 months after ASCT.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">PEG-rhG-CSF (n = 31)</th>
<th align="left" colspan="1" rowspan="1">rhG-CSF (n = 35)</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>ANC, × 10<sup>9</sup>/L (range)</p>
<p>Hemoglobin level, g/L (range)</p>
<p>PLTc, × 10<sup>9</sup>/L (range)</p>
</td>
<td align="center" colspan="1" rowspan="1">
<p>2.9 (1.3–5.3)</p>
<p>127.3 (91–169)</p>
<p>153.1 (86–288)</p>
</td>
<td align="center" colspan="1" rowspan="1">
<p>3.1 (1.6–5.0)</p>
<p>124.7 (65–155)</p>
<p>141.9 (36–233)</p>
</td>
<td align="center" colspan="1" rowspan="1">
<p>0.386</p>
<p>0.586</p>
<p>0.397</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total lymphocyte count, /ul (range)</td>
<td align="center" colspan="1" rowspan="1">1082 (986.6–1215)</td>
<td align="center" colspan="1" rowspan="1">1162 (1013–1318)</td>
<td align="center" colspan="1" rowspan="1">0.397</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD4 + lymphocyte count, /ul (range)</td>
<td align="center" colspan="1" rowspan="1">217.7 (106–313.7)</td>
<td align="center" colspan="1" rowspan="1">344.4 (170–549.2)</td>
<td align="center" colspan="1" rowspan="1">0.313</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD8 + lymphocyte count, /ul (range)</td>
<td align="center" colspan="1" rowspan="1">509 (250.5–668.5)</td>
<td align="center" colspan="1" rowspan="1">598.4 (451.3–769.7)</td>
<td align="center" colspan="1" rowspan="1">0.498</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD19 + lymphocyte count, /ul (range)</td>
<td align="center" colspan="1" rowspan="1">178.1 (5.5–345.5)</td>
<td align="center" colspan="1" rowspan="1">188.9 (80.2–386.4)</td>
<td align="center" colspan="1" rowspan="1">0.930</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD3 + CD56 + lymphocyte count, /ul (range)</td>
<td align="center" colspan="1" rowspan="1">102.3 (5.3–167.2)</td>
<td align="center" colspan="1" rowspan="1">306.5 (34.3–955)</td>
<td align="center" colspan="1" rowspan="1">0.391</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Immunoglobulin G, g/L (range)</td>
<td align="center" colspan="1" rowspan="1">9.6 (6.9–12.3)</td>
<td align="center" colspan="1" rowspan="1">11.0 (4.6–35.8)</td>
<td align="center" colspan="1" rowspan="1">0.686</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Immunoglobulin A, g/L (range)</td>
<td align="center" colspan="1" rowspan="1">1.1 (0.3–2.1)</td>
<td align="center" colspan="1" rowspan="1">0.8 (0–1.6)</td>
<td align="center" colspan="1" rowspan="1">0.188</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Immunoglobulin M, g/L (range)</td>
<td align="center" colspan="1" rowspan="1">0.5 (0.2–1.2)</td>
<td align="center" colspan="1" rowspan="1">0.6 (0–2.1)</td>
<td align="center" colspan="1" rowspan="1">0.602</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p41"><p>ASCT, Autologous hematopoietic stem cell transplantation; PEG-rhG-CSF, Polyethylene glycolized recombinant human granulocyte-stimulating factor; rhG-CSF, Recombinant human granulocyte-stimulating factor; ANC, Absolute neutrophil count; LLN, Lower limit of normal; PLTc, Platelet count.</p></div></div></section></section><section id="Sec14"><h3 class="pmc_sec_title">Economic benefits</h3>
<p id="Par18">The median length of hospitalization did not significantly differ between the two groups, with durations of 27.1 days in the PEG-rhG-CSF group and 26.4 days in the rhG-CSF group (<em>p</em> = 0.499). The median hospitalization cost was RMB 77,126 in the PEG-rhG-CSF group and RMB 68,361 in the rhG-CSF group, showing a statistically significant variance between the groups (<em>p</em> = 0.027). The excess expenditure in the PEG-rhG-CSF group was a median of RMB 8765.</p></section></section><section id="Sec15"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par19">The utilization of rhG-CSF following haematopoietic stem cell transplantation has been shown to decrease the duration of neutropenia and expedite neutrophil engraftment, ultimately mitigating the likelihood of severe infections and engraftment failure<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>. Previous studies have utilized PEG-rhG-CSF to prevent neutropenia following solid tumor chemotherapy, demonstrating a notable superiority over rhG-CSF<sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>. Nevertheless, there remains a scarcity of clinical research on the utilization of PEG-rhG-CSF for hematopoietic reconstitution following ASCT. An analysis of the efficacy, safety, duration of hospitalization, and associated costs between PEG-rhG-CSF and conventional G-CSF in patients with NDMM holds considerable clinical importance and practical value. Such a comparison can offer valuable insights for healthcare providers in making informed clinical decisions.</p>
<p id="Par20">The efficacy of PEG-rhG-CSF in preventing neutropenia following chemotherapy in patients with solid tumors has been validated through clinical trials. A retrospective study was conducted to investigate the effectiveness and safety of primary prophylactic use of PEG-rhG-CSF as supportive care for elderly patients with advanced non-small-cell lung cancer who were chemotherapy-naive and had been treated with docetaxel plus ramucirumab. The study found that only 1 case (1.9%) of FN was observed, and 3 cases (5.6%) experienced grade ≥ 3 neutropenia. These results confirm the high efficacy of PEG-rhG-CSF in preventing FN following chemotherapy for solid tumors<sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. A separate meta-analysis indicated a high level of quality and certainty in the evidence supporting the use of single-dose PEG-rhG-CSF for the primary prevention of febrile neutropenia following chemotherapy, as opposed to multiple-dose injections of non-PEG-rhG-CSF<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>. The prophylactic administration of PEG-rhG-CSF following chemotherapy for solid tumors offers several benefits, including a reduction in the frequency of injection, a decrease in the incidence of febrile neutropenia, a decrease in the need for antibiotics, an improvement in treatment adherence, and a reduction in the financial burden on patients.</p>
<p id="Par21">Nevertheless, there is a scarcity of clinical studies on the use of PEG-rhG-CSF for hematopoietic reconstitution following ASCT. A retrospective study was conducted to assess the efficacy and safety of PEG-rhG-CSF compared to rhG-CSF for hematopoietic recovery following allogeneic hematopoietic stem cell transplantation (allo-HSCT)<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>. The median time to neutrophil engraftment in the PEG-rhG-CSF group was 13.5 days, while in the rhG-CSF group it was 13 days (<em>p</em> = 0.393). Similarly, the median time to platelet engraftment was 14 days in both the PEG-rhG-CSF and rhG-CSF groups (<em>p</em> = 0.094). The results indicate that there was no statistically significant variance in hematopoietic reconstitution between the use of PEG-rhG-CSF and rhG-CSF as supportive therapy following allo-HSCT, suggesting that PEG-rhG-CSF may serve as a viable alternative to rhG-CSF in this context. A multicenter retrospective study was conducted to assess the efficacy and ideal timing of PEG-rhG-CSF following ASCT in lymphoma patients<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>. The study found no statistically significant difference in the duration of neutrophil engraftment between the PEG-rhG-CSF and rhG-CSF cohorts. The duration for neutrophil engraftment was notably reduced when PEG-rhG-CSF was administered on either day 1 or day 3 following hematopoietic stem cell transplantation (9 and 9 days, respectively). This suggests that PEG-rhG-CSF may serve as a viable substitute for rhG-CSF in lymphoma patients undergoing autologous stem cell transplantation.</p>
<p id="Par22">Our study found that there was no statistically significant disparity in neutrophil engraftment time between the two forms of G-CSF, suggesting that PEG-rhG-CSF is comparable to rhG-CSF in facilitating granulopoietic recovery post-ASCT, aligning with findings from prior research<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>,<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>,<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>–<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>. However, in the PEG-rhG-CSF cohort, approximately two-thirds of the patients required supplementary rhG-CSF as a salvage intervention during episodes of febrile neutropenia. Thus, it is not appropriate to assume that PEG-rhG-CSF can serve as a substitute for rhG-CSF in facilitating neutrophil recovery in patients with NDMM following high-dose melphalan conditioning and ASCT.</p>
<p id="Par23">A statistically significant disparity was observed in the timing of platelet engraftment between the two groups, with the PEG-rhG-CSF group exhibiting a notably slower rate. Additionally, the PEG-rhG-CSF group required a significantly higher number of platelet transfusions compared to the rhG-CSF group, a consequence attributed to the delayed platelet engraftment. Thus, our hypothesis posits that PEG-rhG-CSF exerts a negative regulatory influence on platelet engraftment. Ringdén O et al. conducted a study indicating that G-CSF prolongs the time to platelet engraftment following allogeneic bone marrow transplantation<sup><a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>. Subsequent research has indicated that granulocyte colony-stimulating factor (G-CSF) may impede platelet engraftment following hematopoietic stem cell transplantation (HSCT) by obstructing the differentiation of common myeloid progenitors and megakaryocytic-erythroid progenitors into megakaryocytes and platelets<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. Subsequent clinical studies have corroborated the findings of a retrospective analysis which investigated the impact of G-CSF support on hematopoietic reconstitution following allo-HSCT. The analysis revealed a shorter time to platelet engraftment in the control group, which did not receive G-CSF, compared to the experimental group that did receive G-CSF (14 days vs. 18 days, <em>p</em> = 0.015), indicating a potential inhibitory effect of G-CSF on platelet engraftment post-HSCT<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>. A separate investigation examined the impact of a PEG-rhG-CSF biosimilar on hematopoietic recovery following autologous stem cell transplantation in patients with multiple myeloma. Findings from this research indicated a statistically significant increase in the number of platelet transfusions required in the PEG-rhG-CSF biosimilar cohort compared to the rhG-CSF cohort (2 units vs. 1 unit, <em>p</em> &lt; 0.01), suggesting a potential delay in platelet engraftment associated with PEG-rhG-CSF<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. Our study has provided novel findings indicating that the use of PEG-rhG-CSF following ASCT in patients with NDMM results in prolonged platelet engraftment time and increased platelet transfusion requirements. These results have significant clinical implications and warrant further investigation. Our hypothesis posits that PEG-rhG-CSF exerts a more pronounced inhibitory influence on platelet engraftment compared to rhG-CSF, attributable to its distinct pharmacokinetic profile. Given the limited sample size in this study, additional validation is required through enlargement of the sample size in subsequent investigations. Concurrently, animal modeling studies will be conducted to delve deeper into the underlying mechanisms.</p>
<p id="Par24">Grade ≥ 3 adverse reactions, primarily hematologic toxicities such as neutropenia and thrombocytopenia, were observed in both groups in this study, aligning with findings from prior research. Conversely, non-hematological adverse reactions, including mucositis, renal insufficiency, and transaminase elevation, were predominantly ≤ grade 2, indicating a manageable level of safety. The increased incidence and extended duration of grade 3–4 diarrhea observed in the PEG-rhG-CSF cohort in this study may be ascribed to several factors: the slower rate of granulocyte elevation, mucosal damage resulting from melphalan administration, and impairment of the intestinal mucosal barrier in the absence of neutrophilic cells, which may predispose patients to concurrent infections. Furthermore, PEG-rhG-CSF is known to have diarrhea as a potential adverse effect. Compared to PEG-rhG-CSF, rhG-CSF was associated with a reduction in the severity of diarrhea and a shorter duration of symptoms. This finding, which contradicts previous research, warrants further investigation through prospective studies with larger sample sizes to confirm its validity<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>.</p>
<p id="Par25">While there was no significant statistical variance in the duration of hospital stays between the two cohorts, the median hospitalization expenses in the PEG-rhG-CSF group rose by RMB 8765. Initially, 66.7% of patients in the PEG-rhG-CSF group received additional rhG-CSF during FN. Subsequently, patients in this group exhibited an extended platelet engraftment period and a higher frequency of platelet transfusions. Additionally, the PEG-rhG-CSF cohort demonstrated a slightly elevated incidence of grade 3–4 diarrhea and prolonged duration of diarrhea, necessitating a greater number of intravenous nutritional interventions. Lastly, the PEG-rhG-CSF group experienced a marginally prolonged duration of neutropenia and increased utilization of antibiotics. These factors are probable contributors to the discrepancy in hospitalization costs noted between the two groups.</p>
<p id="Par26">Our study has some limitations. Initially, the limited sample size and absence of random sampling may introduce selection bias in the findings. Furthermore, due to the diverse and unique characteristics of patients with multiple myeloma, efforts were made to enhance the uniformity of the study cohort by retrospectively selecting individuals eligible for transplantation who received BRD induction therapy for a duration of 4 cycles, while excluding those treated with alternative regimens such as bortezomib plus cyclophosphamide and dexamethasone (BCD), bortezomib plus thalidomide and dexamethasone (BTD), and daratumumab plus BRD (D-BRD). However, the reliability of results across various samples remains uncertain. Additionally, retrospective studies are inherently influenced by subjective factors, and the accuracy of medical records is not regulated by the study’s design, leading to potential confounding variables and bias. Therefore, future research should focus on conducting prospective clinical studies with larger sample sizes.</p></section><section id="Sec16"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par27">No advantage was found for hematopoietic reconstitution after ASCT in the PEG-rhG-CSF group compared to the control group supported by rhG-CSF. Notably, the administration of PEG-rhG-CSF has been associated with an extended duration for platelet engraftment and an increased frequency of platelet transfusions. Furthermore, individuals receiving PEG-rhG-CSF support exhibited a higher incidence and longer duration of severe diarrhea, as well as increased median hospitalization costs. Therefore, it appears that PEG-rhG-CSF may be a more expensive choice for supportive treatment following ASCT in NDMM.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The research was conducted by a multidisciplinary team of clinicians affiliated with the Department of Oncology and Hematology, the Central Research Laboratory, and the Medical Laboratory Center of China-Japan Union Hospital at Jilin University.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>W.Z. concepted and designed the study. Z.Z., D. C., Y. B., W. Z. provide study materials or patients. R.W. and H. T. collected the data wrote the main manuscript text. All authors reviewed the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by grants from Science and Technology Development Project of Jilin Province (YDZJ202201ZYTS092 to WZ) and Natural Science Foundation of Jilin Province (20210401174YY to WZ). The source of funding had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The deidentified data generated in this study are available upon appropriate request to the corresponding author at wenxu@jlu.edu.cn.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par28">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Ruiqi Wang and Hao Tian equally contributed to this work and co-first authors.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Bazarbachi, A. H. et al. Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: An update. <em>Blood Cancer J.</em><strong>12</strong>, 47. 10.1038/s41408-022-00645-1 (2022).
</cite> [<a href="https://doi.org/10.1038/s41408-022-00645-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8960754/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35347107/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bazarbachi,%20A.%20H.%20et%20al.%20Induction%20therapy%20prior%20to%20autologous%20stem%20cell%20transplantation%20(ASCT)%20in%20newly%20diagnosed%20multiple%20myeloma:%20An%20update.%20Blood%20Cancer%20J.12,%2047.%2010.1038/s41408-022-00645-1%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Jantunen, E. et al. Early treatment-related mortality in adult autologous stem cell transplant recipients: A nation-wide survey of 1482 transplanted patients. <em>Eur. J. Haematol.</em><strong>76</strong>, 245–250. 10.1111/j.1600-0609.2005.00605.x (2006).
</cite> [<a href="https://doi.org/10.1111/j.1600-0609.2005.00605.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16412136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jantunen,%20E.%20et%20al.%20Early%20treatment-related%20mortality%20in%20adult%20autologous%20stem%20cell%20transplant%20recipients:%20A%20nation-wide%20survey%20of%201482%20transplanted%20patients.%20Eur.%20J.%20Haematol.76,%20245%E2%80%93250.%2010.1111/j.1600-0609.2005.00605.x%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Hassan, M. N. et al. Autologous peripheral blood stem cell transplantation among lymphoproliferative disease patients: Factors influencing engraftment. <em>Oman Med. J.</em><strong>34</strong>, 34–43. 10.5001/omj.2019.06 (2019).
</cite> [<a href="https://doi.org/10.5001/omj.2019.06" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6330180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30671182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hassan,%20M.%20N.%20et%20al.%20Autologous%20peripheral%20blood%20stem%20cell%20transplantation%20among%20lymphoproliferative%20disease%20patients:%20Factors%20influencing%20engraftment.%20Oman%20Med.%20J.34,%2034%E2%80%9343.%2010.5001/omj.2019.06%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Aladağ Karakulak, E. et al. CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation. <em>Turk. J. Med. Sci.</em><strong>50</strong>, 1851–1856. 10.3906/sag-2001-173 (2020).
</cite> [<a href="https://doi.org/10.3906/sag-2001-173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7775700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32512672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alada%C4%9F%20Karakulak,%20E.%20et%20al.%20CD34+%20hematopoietic%20progenitor%20cell%20dose%20as%20a%20predictor%20of%20engraftment%20and%20survival%20in%20multiple%20myeloma%20patients%20undergoing%20autologous%20stem%20cell%20transplantation.%20Turk.%20J.%20Med.%20Sci.50,%201851%E2%80%931856.%2010.3906/sag-2001-173%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Serin, I. et al. Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?. <em>Transfus. Apher. Sci. Off. J. World Apher. Assoc. Off. J. Eur. Soc. Haemapher.</em><strong>62</strong>, 103809. 10.1016/j.transci.2023.103809 (2023).</cite> [<a href="https://doi.org/10.1016/j.transci.2023.103809" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37690861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Serin,%20I.%20et%20al.%20Plerixafor%20in%20autologous%20stem%20cell%20transplantation:%20Does%20it%20affect%20engraftment%20kinetics?.%20Transfus.%20Apher.%20Sci.%20Off.%20J.%20World%20Apher.%20Assoc.%20Off.%20J.%20Eur.%20Soc.%20Haemapher.62,%20103809.%2010.1016/j.transci.2023.103809%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Pham, T. et al. Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation. <em>Transfusion</em><strong>55</strong>, 2709–2713. 10.1111/trf.13233 (2015).
</cite> [<a href="https://doi.org/10.1111/trf.13233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26173921/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pham,%20T.%20et%20al.%20Comparison%20of%20biosimilar%20filgrastim%20with%20originator%20filgrastim%20for%20peripheral%20blood%20stem%20cell%20mobilization%20and%20engraftment%20in%20patients%20with%20multiple%20myeloma%20undergoing%20autologous%20stem%20cell%20transplantation.%20Transfusion55,%202709%E2%80%932713.%2010.1111/trf.13233%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Bassi, S. et al. Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: A 4-year, single institute experience with different conditioning regimens. <em>Blood Transfus. Trasfusione del sangue</em><strong>13</strong>, 478–483. 10.2450/2015.0198-14 (2015).
</cite> [<a href="https://doi.org/10.2450/2015.0198-14" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4614302/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25761321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bassi,%20S.%20et%20al.%20Safety%20and%20efficacy%20of%20granulocyte%20colony-stimulating%20factor%20biosimilars%20in%20engraftment%20after%20autologous%20stem%20cell%20transplantation%20for%20haematological%20malignancies:%20A%204-year,%20single%20institute%20experience%20with%20different%20conditioning%20regimens.%20Blood%20Transfus.%20Trasfusione%20del%20sangue13,%20478%E2%80%93483.%2010.2450/2015.0198-14%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Serin, I. et al. Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?. <em>Transfus. Apher. Sci.</em><strong>62</strong>, 103809. 10.1016/j.transci.2023.103809 (2023).
</cite> [<a href="https://doi.org/10.1016/j.transci.2023.103809" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37690861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Serin,%20I.%20et%20al.%20Plerixafor%20in%20autologous%20stem%20cell%20transplantation:%20Does%20it%20affect%20engraftment%20kinetics?.%20Transfus.%20Apher.%20Sci.62,%20103809.%2010.1016/j.transci.2023.103809%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Klein, E. M. et al. Antibiotic prophylaxis or granulocyte-colony stimulating factor support in multiple myeloma patients undergoing autologous stem cell transplantation. <em>Cancers</em><strong>13</strong>, 3439. 10.3390/cancers13143439 (2021).
</cite> [<a href="https://doi.org/10.3390/cancers13143439" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8303829/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34298654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klein,%20E.%20M.%20et%20al.%20Antibiotic%20prophylaxis%20or%20granulocyte-colony%20stimulating%20factor%20support%20in%20multiple%20myeloma%20patients%20undergoing%20autologous%20stem%20cell%20transplantation.%20Cancers13,%203439.%2010.3390/cancers13143439%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Singh, V. et al. G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD. <em>Leuk. Lymphoma</em><strong>62</strong>, 446–453. 10.1080/10428194.2020.1827244 (2021).
</cite> [<a href="https://doi.org/10.1080/10428194.2020.1827244" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33043743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singh,%20V.%20et%20al.%20G-CSF%20use%20post%20peripheral%20blood%20stem%20cell%20transplant%20is%20associated%20with%20faster%20neutrophil%20engraftment,%20shorter%20hospital%20stay%20and%20increased%20incidence%20of%20chronic%20GVHD.%20Leuk.%20Lymphoma62,%20446%E2%80%93453.%2010.1080/10428194.2020.1827244%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Cioch, M. et al. Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation. <em>Transpl. Proc.</em><strong>46</strong>, 2882–2884. 10.1016/j.transproceed.2014.09.070 (2014).</cite> [<a href="https://doi.org/10.1016/j.transproceed.2014.09.070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25380941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cioch,%20M.%20et%20al.%20Biosimilar%20granulocyte%20colony-stimulating%20factor%20is%20effective%20in%20reducing%20the%20duration%20of%20neutropenia%20after%20autologous%20peripheral%20blood%20stem%20cell%20transplantation.%20Transpl.%20Proc.46,%202882%E2%80%932884.%2010.1016/j.transproceed.2014.09.070%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Singh, A. D. et al. Granulocyte colony-stimulating factor use after autologous peripheral blood stem cell transplantation: Comparison of two practices. <em>Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant.</em><strong>24</strong>, 288–293. 10.1016/j.bbmt.2017.10.026 (2018).</cite> [<a href="https://doi.org/10.1016/j.bbmt.2017.10.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6574227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29061534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singh,%20A.%20D.%20et%20al.%20Granulocyte%20colony-stimulating%20factor%20use%20after%20autologous%20peripheral%20blood%20stem%20cell%20transplantation:%20Comparison%20of%20two%20practices.%20Biol.%20Blood%20Marrow%20Transplant.%20J.%20Am.%20Soc.%20Blood%20Marrow%20Transplant.24,%20288%E2%80%93293.%2010.1016/j.bbmt.2017.10.026%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Molineux, G. Pegfilgrastim: Using pegylation technology to improve neutropenia support in cancer patients. <em>Anticancer Drugs</em><strong>14</strong>, 259–264. 10.1097/00001813-200304000-00002 (2003).
</cite> [<a href="https://doi.org/10.1097/00001813-200304000-00002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12679729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Molineux,%20G.%20Pegfilgrastim:%20Using%20pegylation%20technology%20to%20improve%20neutropenia%20support%20in%20cancer%20patients.%20Anticancer%20Drugs14,%20259%E2%80%93264.%2010.1097/00001813-200304000-00002%20(2003)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Roder, L., Konrardy, K., Grauer, D. &amp; Hoffmann, M. Effects of filgrastim versus pegfilgrastim on outcomes of DA-R-EPOCH for non-Hodgkin’s lymphoma. <em>Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer</em><strong>29</strong>, 5075–5082. 10.1007/s00520-021-06045-8 (2021).</cite> [<a href="https://doi.org/10.1007/s00520-021-06045-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33594515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roder,%20L.,%20Konrardy,%20K.,%20Grauer,%20D.%20&amp;%20Hoffmann,%20M.%20Effects%20of%20filgrastim%20versus%20pegfilgrastim%20on%20outcomes%20of%20DA-R-EPOCH%20for%20non-Hodgkin%E2%80%99s%20lymphoma.%20Support.%20Care%20Cancer%20Off.%20J.%20Multinatl.%20Assoc.%20Support.%20Care%20Cancer29,%205075%E2%80%935082.%2010.1007/s00520-021-06045-8%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Gebremariam, G. T., Fentie, A. M., Beyene, K., Sander, B. &amp; Gebretekle, G. B. Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: A systematic review. <em>BMC Health Serv. Res.</em><strong>22</strong>, 1600. 10.1186/s12913-022-08933-z (2022).
</cite> [<a href="https://doi.org/10.1186/s12913-022-08933-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9805270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36585648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gebremariam,%20G.%20T.,%20Fentie,%20A.%20M.,%20Beyene,%20K.,%20Sander,%20B.%20&amp;%20Gebretekle,%20G.%20B.%20Cost-effectiveness%20of%20pegfilgrastim%20versus%20filgrastim%20for%20prevention%20of%20chemotherapy-induced%20febrile%20neutropenia%20in%20patients%20with%20lymphoma:%20A%20systematic%20review.%20BMC%20Health%20Serv.%20Res.22,%201600.%2010.1186/s12913-022-08933-z%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Zhu, X. et al. Pegfilgrastim on febrile neutropenia in pediatric and adolescent cancer patients: A systematic review and meta-analysis. <em>Hematology</em><strong>28</strong>, 2172292. 10.1080/16078454.2023.2172292 (2023).
</cite> [<a href="https://doi.org/10.1080/16078454.2023.2172292" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36719297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu,%20X.%20et%20al.%20Pegfilgrastim%20on%20febrile%20neutropenia%20in%20pediatric%20and%20adolescent%20cancer%20patients:%20A%20systematic%20review%20and%20meta-analysis.%20Hematology28,%202172292.%2010.1080/16078454.2023.2172292%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Gwak, H. et al. COVID-19 prevention guidance and the incidence of febrile neutropenia in patients with breast cancer receiving TAC chemotherapy with prophylactic pegfilgrastim. <em>J. Clin. Med.</em>10.3390/jcm11237053 (2022).
</cite> [<a href="https://doi.org/10.3390/jcm11237053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9737023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36498628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gwak,%20H.%20et%20al.%20COVID-19%20prevention%20guidance%20and%20the%20incidence%20of%20febrile%20neutropenia%20in%20patients%20with%20breast%20cancer%20receiving%20TAC%20chemotherapy%20with%20prophylactic%20pegfilgrastim.%20J.%20Clin.%20Med.10.3390/jcm11237053%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Kurogochi, T. et al. Efficacy and cost-effectiveness of pegfilgrastim for preventing febrile neutropenia during docetaxel, cisplatin, and 5-fluorouracil therapy for esophageal cancer. <em>Anticancer Res.</em><strong>43</strong>, 2293–2298. 10.21873/anticanres.16393 (2023).
</cite> [<a href="https://doi.org/10.21873/anticanres.16393" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37097646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kurogochi,%20T.%20et%20al.%20Efficacy%20and%20cost-effectiveness%20of%20pegfilgrastim%20for%20preventing%20febrile%20neutropenia%20during%20docetaxel,%20cisplatin,%20and%205-fluorouracil%20therapy%20for%20esophageal%20cancer.%20Anticancer%20Res.43,%202293%E2%80%932298.%2010.21873/anticanres.16393%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Moon, Y. W. et al. Eflapegrastim versus pegfilgrastim for chemotherapy-induced neutropenia in Korean and Asian patients with early breast cancer: Results from the two phase iii advance and recover studies. <em>Cancer Res. Treat.</em><strong>55</strong>, 766–777. 10.4143/crt.2022.987 (2023).
</cite> [<a href="https://doi.org/10.4143/crt.2022.987" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10372586/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36701846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moon,%20Y.%20W.%20et%20al.%20Eflapegrastim%20versus%20pegfilgrastim%20for%20chemotherapy-induced%20neutropenia%20in%20Korean%20and%20Asian%20patients%20with%20early%20breast%20cancer:%20Results%20from%20the%20two%20phase%20iii%20advance%20and%20recover%20studies.%20Cancer%20Res.%20Treat.55,%20766%E2%80%93777.%2010.4143/crt.2022.987%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Martino, M. et al. Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation. <em>Ann. Hematol.</em><strong>102</strong>, 1915–1925. 10.1007/s00277-023-05228-z (2023).
</cite> [<a href="https://doi.org/10.1007/s00277-023-05228-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10281896/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37079070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Martino,%20M.%20et%20al.%20Effectiveness%20of%20biosimilar%20pegfilgrastim%20in%20patients%20with%20multiple%20myeloma%20after%20high-dose%20melphalan%20and%20autologous%20stem%20cell%20transplantation.%20Ann.%20Hematol.102,%201915%E2%80%931925.%2010.1007/s00277-023-05228-z%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Gonsalves, W. I. et al. Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: A mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus statement. <em>Bone Marrow Transplant.</em><strong>54</strong>, 353–367. 10.1038/s41409-018-0264-8 (2019).
</cite> [<a href="https://doi.org/10.1038/s41409-018-0264-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6463224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29988062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gonsalves,%20W.%20I.%20et%20al.%20Utilization%20of%20hematopoietic%20stem%20cell%20transplantation%20for%20the%20treatment%20of%20multiple%20myeloma:%20A%20mayo%20stratification%20of%20myeloma%20and%20risk-adapted%20therapy%20(mSMART)%20consensus%20statement.%20Bone%20Marrow%20Transplant.54,%20353%E2%80%93367.%2010.1038/s41409-018-0264-8%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Greipp, P. R. et al. International staging system for multiple myeloma. <em>J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.</em><strong>23</strong>, 3412–3420. 10.1200/jco.2005.04.242 (2005).</cite> [<a href="https://doi.org/10.1200/JCO.2005.04.242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15809451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Greipp,%20P.%20R.%20et%20al.%20International%20staging%20system%20for%20multiple%20myeloma.%20J.%20Clin.%20Oncol.%20Off.%20J.%20Am.%20Soc.%20Clin.%20Oncol.23,%203412%E2%80%933420.%2010.1200/jco.2005.04.242%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Palumbo, A. et al. Revised international staging system for multiple myeloma: A report from international myeloma working group. <em>J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.</em><strong>33</strong>, 2863–2869. 10.1200/jco.2015.61.2267 (2015).</cite> [<a href="https://doi.org/10.1200/JCO.2015.61.2267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4846284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26240224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Palumbo,%20A.%20et%20al.%20Revised%20international%20staging%20system%20for%20multiple%20myeloma:%20A%20report%20from%20international%20myeloma%20working%20group.%20J.%20Clin.%20Oncol.%20Off.%20J.%20Am.%20Soc.%20Clin.%20Oncol.33,%202863%E2%80%932869.%2010.1200/jco.2015.61.2267%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Cavallo, F. et al. Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy. <em>Leukemia</em><strong>25</strong>, 1627–1631. 10.1038/leu.2011.131 (2011).
</cite> [<a href="https://doi.org/10.1038/leu.2011.131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21637283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cavallo,%20F.%20et%20al.%20Stem%20cell%20mobilization%20in%20patients%20with%20newly%20diagnosed%20multiple%20myeloma%20after%20lenalidomide%20induction%20therapy.%20Leukemia25,%201627%E2%80%931631.%2010.1038/leu.2011.131%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Huijgens, P. C. et al. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology. <em>J. Clin. Pathol.</em><strong>52</strong>, 376–380. 10.1136/jcp.52.5.376 (1999).
</cite> [<a href="https://doi.org/10.1136/jcp.52.5.376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1023076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10560360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huijgens,%20P.%20C.%20et%20al.%20Fluconazole%20versus%20itraconazole%20for%20the%20prevention%20of%20fungal%20infections%20in%20haemato-oncology.%20J.%20Clin.%20Pathol.52,%20376%E2%80%93380.%2010.1136/jcp.52.5.376%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Gkirkas, K. et al. Low-dose cotrimoxazole administered in hematopoietic stem cell transplant recipients as prophylaxis for <em>Pneumocystis jirovecii</em> pneumonia is effective in prevention of infection due to nocardia. <em>Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant.</em><strong>25</strong>, e298–e299. 10.1016/j.bbmt.2019.07.018 (2019).</cite> [<a href="https://doi.org/10.1016/j.bbmt.2019.07.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31326612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gkirkas,%20K.%20et%20al.%20Low-dose%20cotrimoxazole%20administered%20in%20hematopoietic%20stem%20cell%20transplant%20recipients%20as%20prophylaxis%20for%20Pneumocystis%20jirovecii%20pneumonia%20is%20effective%20in%20prevention%20of%20infection%20due%20to%20nocardia.%20Biol.%20Blood%20Marrow%20Transplant.%20J.%20Am.%20Soc.%20Blood%20Marrow%20Transplant.25,%20e298%E2%80%93e299.%2010.1016/j.bbmt.2019.07.018%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Wang, X., Ren, J., Liang, X. &amp; He, P. Efficacy and cost of G-CSF derivatives for prophylaxis of febrile neutropenia in lymphoma and multiple myeloma patients underwent autologous hematopoietic stem cell transplantation. <em>Hematology</em><strong>26</strong>, 950–955. 10.1080/16078454.2021.2003071 (2021).
</cite> [<a href="https://doi.org/10.1080/16078454.2021.2003071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34904529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20X.,%20Ren,%20J.,%20Liang,%20X.%20&amp;%20He,%20P.%20Efficacy%20and%20cost%20of%20G-CSF%20derivatives%20for%20prophylaxis%20of%20febrile%20neutropenia%20in%20lymphoma%20and%20multiple%20myeloma%20patients%20underwent%20autologous%20hematopoietic%20stem%20cell%20transplantation.%20Hematology26,%20950%E2%80%93955.%2010.1080/16078454.2021.2003071%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Portuguese, A. J. et al. Revisiting the utility of granulocyte colony-stimulating factor post-autologous hematopoietic stem cell transplantation for outpatient-based transplantations. <em>Transplant. Cell Ther.</em><strong>29</strong>, 696.e691-696.e697. 10.1016/j.jtct.2023.08.021 (2023).</cite> [<a href="https://doi.org/10.1016/j.jtct.2023.08.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10840691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37634844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Portuguese,%20A.%20J.%20et%20al.%20Revisiting%20the%20utility%20of%20granulocyte%20colony-stimulating%20factor%20post-autologous%20hematopoietic%20stem%20cell%20transplantation%20for%20outpatient-based%20transplantations.%20Transplant.%20Cell%20Ther.29,%20696.e691-696.e697.%2010.1016/j.jtct.2023.08.021%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Qin, Y. et al. A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia. <em>Chin. J. Cancer Res.</em><strong>29</strong>, 402–410. 10.21147/j.issn.1000-9604.2017.05.04 (2017).
</cite> [<a href="https://doi.org/10.21147/j.issn.1000-9604.2017.05.04" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5675917/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29142459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qin,%20Y.%20et%20al.%20A%20phase%20I%20study%20of%20different%20doses%20and%20frequencies%20of%20pegylated%20recombinant%20human%20granulocyte-colony%20stimulating%20factor%20(PEG%20rhG-CSF)%20in%20patients%20with%20standard-dose%20chemotherapy-induced%20neutropenia.%20Chin.%20J.%20Cancer%20Res.29,%20402%E2%80%93410.%2010.21147/j.issn.1000-9604.2017.05.04%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Zubair, A. C. et al. CD34(+) CD38(−) and CD34(+) HLA-DR(−) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation. <em>Cytotherapy</em><strong>8</strong>, 399–407. 10.1080/14653240600847241 (2006).
</cite> [<a href="https://doi.org/10.1080/14653240600847241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16923616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zubair,%20A.%20C.%20et%20al.%20CD34(+)%20CD38(%E2%88%92)%20and%20CD34(+)%20HLA-DR(%E2%88%92)%20cells%20in%20BM%20stem%20cell%20grafts%20correlate%20with%20short-term%20engraftment%20but%20have%20no%20influence%20on%20long-term%20hematopoietic%20reconstitution%20after%20autologous%20transplantation.%20Cytotherapy8,%20399%E2%80%93407.%2010.1080/14653240600847241%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Goldsmith, S. R. et al. A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma. <em>Ann. Hematol.</em><strong>103</strong>, 4557–4565. 10.1007/s00277-024-05975-7 (2024).
</cite> [<a href="https://doi.org/10.1007/s00277-024-05975-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39227452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goldsmith,%20S.%20R.%20et%20al.%20A%20phase%20Ib%20trial%20of%20isatuximab,%20bendamustine,%20and%20prednisone%20in%20relapsed/refractory%20multiple%20myeloma.%20Ann.%20Hematol.103,%204557%E2%80%934565.%2010.1007/s00277-024-05975-7%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Li, X. et al. Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis. <em>Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer</em><strong>28</strong>, 5085–5097. 10.1007/s00520-020-05603-w (2020).</cite> [<a href="https://doi.org/10.1007/s00520-020-05603-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7333975/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32621264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li,%20X.%20et%20al.%20Is%20PEGylated%20G-CSF%20superior%20to%20G-CSF%20in%20patients%20with%20breast%20cancer%20receiving%20chemotherapy?%20A%20systematic%20review%20and%20meta-analysis.%20Support.%20Care%20Cancer%20Off.%20J.%20Multinatl.%20Assoc.%20Support.%20Care%20Cancer28,%205085%E2%80%935097.%2010.1007/s00520-020-05603-w%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Tachihara, M. et al. Docetaxel plus ramucirumab with primary prophylactic pegylated granulocyte-colony stimulating factor support for elderly patients with advanced NSCLC: A multicenter prospective single arm phase 2 trial: Dragon study (WJOG9416L). <em>JTO Clin. Res. Rep.</em><strong>4</strong>, 100569. 10.1016/j.jtocrr.2023.100569 (2023).
</cite> [<a href="https://doi.org/10.1016/j.jtocrr.2023.100569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10563050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37822699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tachihara,%20M.%20et%20al.%20Docetaxel%20plus%20ramucirumab%20with%20primary%20prophylactic%20pegylated%20granulocyte-colony%20stimulating%20factor%20support%20for%20elderly%20patients%20with%20advanced%20NSCLC:%20A%20multicenter%20prospective%20single%20arm%20phase%202%20trial:%20Dragon%20study%20(WJOG9416L).%20JTO%20Clin.%20Res.%20Rep.4,%20100569.%2010.1016/j.jtocrr.2023.100569%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Yoshinami, T. et al. Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: A systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022. <em>Int. J. Clin. Oncol.</em><strong>29</strong>, 681–688. 10.1007/s10147-024-02504-4 (2024).
</cite> [<a href="https://doi.org/10.1007/s10147-024-02504-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38649648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yoshinami,%20T.%20et%20al.%20Comparison%20between%20a%20single%20dose%20of%20PEG%20G-CSF%20and%20multiple%20doses%20of%20non-PEG%20G-CSF:%20A%20systematic%20review%20and%20meta-analysis%20from%20clinical%20practice%20guidelines%20for%20the%20use%20of%20G-CSF%202022.%20Int.%20J.%20Clin.%20Oncol.29,%20681%E2%80%93688.%2010.1007/s10147-024-02504-4%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Yang, F. et al. [Comparative study on the efficacy and safety between pegfilgrastim (PEG-rhG-CSF) and recombinant human granulocyte colony-stimulating factor in promoting hematopoietic recovery after allogeneic hematopoietic stem cell transplantation after hematological malignancy]. <em>Zhonghua xue ye xue za zhi Zhonghua xueyexue zazhi</em><strong>38</strong>, 831–836. 10.3760/cma.j.issn.0253-2727.2017.10.002 (2017).
</cite> [<a href="https://doi.org/10.3760/cma.j.issn.0253-2727.2017.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7364959/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29166733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang,%20F.%20et%20al.%20%5BComparative%20study%20on%20the%20efficacy%20and%20safety%20between%20pegfilgrastim%20(PEG-rhG-CSF)%20and%20recombinant%20human%20granulocyte%20colony-stimulating%20factor%20in%20promoting%20hematopoietic%20recovery%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation%20after%20hematological%20malignancy%5D.%20Zhonghua%20xue%20ye%20xue%20za%20zhi%20Zhonghua%20xueyexue%20zazhi38,%20831%E2%80%93836.%2010.3760/cma.j.issn.0253-2727.2017.10.002%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Li, S. et al. The effectiveness and optimal timing of PEG-rhG-CSF after autologous peripheral blood stem cell transplantation: A multicenter experience. <em>Indian J. Hematol. Blood Transfus. Off. J. Indian Soc. of Hematol. Blood Transfus.</em><strong>40</strong>, 190–195. 10.1007/s12288-023-01704-8 (2024).</cite> [<a href="https://doi.org/10.1007/s12288-023-01704-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11065841/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38708162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li,%20S.%20et%20al.%20The%20effectiveness%20and%20optimal%20timing%20of%20PEG-rhG-CSF%20after%20autologous%20peripheral%20blood%20stem%20cell%20transplantation:%20A%20multicenter%20experience.%20Indian%20J.%20Hematol.%20Blood%20Transfus.%20Off.%20J.%20Indian%20Soc.%20of%20Hematol.%20Blood%20Transfus.40,%20190%E2%80%93195.%2010.1007/s12288-023-01704-8%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Castagna, L. et al. Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support. <em>Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.</em><strong>21</strong>, 1482–1485. 10.1093/annonc/mdp576 (2010).</cite> [<a href="https://doi.org/10.1093/annonc/mdp576" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20007996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Castagna,%20L.%20et%20al.%20Pegfilgrastim%20versus%20filgrastim%20after%20high-dose%20chemotherapy%20and%20autologous%20peripheral%20blood%20stem%20cell%20support.%20Ann.%20Oncol.%20Off.%20J.%20Eur.%20Soc.%20Med.%20Oncol.21,%201482%E2%80%931485.%2010.1093/annonc/mdp576%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Vanstraelen, G. et al. Pegfilgrastim compared with filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. <em>Exp. Hematol.</em><strong>34</strong>, 382–388. 10.1016/j.exphem.2005.11.013 (2006).
</cite> [<a href="https://doi.org/10.1016/j.exphem.2005.11.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16543072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vanstraelen,%20G.%20et%20al.%20Pegfilgrastim%20compared%20with%20filgrastim%20after%20autologous%20hematopoietic%20peripheral%20blood%20stem%20cell%20transplantation.%20Exp.%20Hematol.34,%20382%E2%80%93388.%2010.1016/j.exphem.2005.11.013%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Ringdén, O. et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: A study from the acute leukemia working party of the European group for blood and marrow transplantation. <em>J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.</em><strong>22</strong>, 416–423. 10.1200/jco.2004.06.102 (2004).</cite> [<a href="https://doi.org/10.1200/JCO.2004.06.102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14691124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ringd%C3%A9n,%20O.%20et%20al.%20Treatment%20with%20granulocyte%20colony-stimulating%20factor%20after%20allogeneic%20bone%20marrow%20transplantation%20for%20acute%20leukemia%20increases%20the%20risk%20of%20graft-versus-host%20disease%20and%20death:%20A%20study%20from%20the%20acute%20leukemia%20working%20party%20of%20the%20European%20group%20for%20blood%20and%20marrow%20transplantation.%20J.%20Clin.%20Oncol.%20Off.%20J.%20Am.%20Soc.%20Clin.%20Oncol.22,%20416%E2%80%93423.%2010.1200/jco.2004.06.102%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Li, Y. et al. G-CSF administration results in thrombocytopenia by inhibiting the differentiation of hematopoietic progenitors into megakaryocytes. <em>Biochem. Pharmacol.</em><strong>169</strong>, 113624. 10.1016/j.bcp.2019.113624 (2019).
</cite> [<a href="https://doi.org/10.1016/j.bcp.2019.113624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31473203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li,%20Y.%20et%20al.%20G-CSF%20administration%20results%20in%20thrombocytopenia%20by%20inhibiting%20the%20differentiation%20of%20hematopoietic%20progenitors%20into%20megakaryocytes.%20Biochem.%20Pharmacol.169,%20113624.%2010.1016/j.bcp.2019.113624%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Sarıcı, A. et al. The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers. <em>Transfus. Apher. Sci. Off. J. World Apher. Assoc. Off. J. Eur. Soc. Haemapher.</em><strong>61</strong>, 103482. 10.1016/j.transci.2022.103482 (2022).</cite> [<a href="https://doi.org/10.1016/j.transci.2022.103482" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35718683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sar%C4%B1c%C4%B1,%20A.%20et%20al.%20The%20effect%20of%20G-CSF%20used%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation%20on%20engraftment%20times%20and%20platelet%20suspension%20replacement%20numbers.%20Transfus.%20Apher.%20Sci.%20Off.%20J.%20World%20Apher.%20Assoc.%20Off.%20J.%20Eur.%20Soc.%20Haemapher.61,%20103482.%2010.1016/j.transci.2022.103482%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The deidentified data generated in this study are available upon appropriate request to the corresponding author at wenxu@jlu.edu.cn.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-15360-7"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_15360.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373793/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373793/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373793%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373793/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373793/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373793/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40846723/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373793/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40846723/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373793/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373793/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="ZMhgtEsmktMdy2o64dkTxJ5WtzeKtt4AbVenbPtgpjnWgxyxEgyMccsTMs84IBVn">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
